Delivery Order SPE2DB20D1047-SPE2DB25FF85C
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,072.25 by the Defense Logistics Agency's Medical Supply Chain for the procurement of Pegasys 180 mcg/ml vials. This firm fixed-price, competitively awarded contract (no set-aside) was issued on September 10, 2025, with an ultimate completion date of September 11, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its Corporate Office location. This delivery order represents a child award...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,752.22 on May 20, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price, competitively awarded contract (no set-aside used) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this delivery order from its corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a $2,072.25 delivery order to AmerisourceBergen Drug Corp for Pegasys 180 mcg/ml vials, with an ultimate completion date of September 15, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing for pharmaceutical supply fulfillment. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,261.21 by the Defense Logistics Agency (DLA) for the supply of Pegasys 180 mcg/ml vials. The award, issued on July 28, 2025, is a firm fixed price contract with an ultimate completion date of July 29, 2025. This non-set-aside delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,752.22 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Pegasys 180 mcg/0.5 mL syringes. This is a firm fixed price contract with an ultimate completion date of August 22, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the...
- The Defense Logistics Agency awarded a delivery order valued at $2,752.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/0.5 mL syringes on September 9, 2025, with completion scheduled for September 10, 2025. This firm fixed-price contract, which was not set aside for small business or other designated categories, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,726.23 to AmerisourceBergen Drug Corp for Pegasys 180 mcg/ml vials on June 2, 2025, with completion scheduled for June 3, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger federal procurement relationship. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,515.38 for Pegasys 180 mcg/ml vials on April 21, 2025, with completion scheduled for April 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate office location in Conshohocken, PA. The award is funded by the Defense Logistics Agency's Medical Supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,833.83 on September 2, 2025, for Pegasys 180 mcg/mL vials to support the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 3, 2025, with performance taking place at the contractor's Conshohocken facility. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PEGASYS 180 MCG/ML VIALML pharmaceuticals. The contract has a potential value of $8,220.18 and a completion date of January 26, 2024. This delivery order contract is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025. The...